Thames Valley pilot study to check for rare condition
First UK pilot study of newborn screening for SMA was launched in Oxford. The aim of the study is to […]
Read moreArchive: Mar 2022
Latest data from Novartis SPRINT trial of Zolgensma confirms the benefits of pre-symptomatic treatment
Latest data from the SPR1NT trial has been released, again confirming the impact of Zolgensma for children at risk for […]
Read more